Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer |
Carboplatin, Comprehensive Geriatric Assessment, Pembrolizumab, Pemetrexed, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients |
Megestrol Acetate, Olanzapine, Questionnaire Administration |
Recruiting |
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer |
metformin hydrochloride, placebo |
Active, not recruiting |
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making |
Usual Care, Web-based decision aid |
Active, not recruiting |
MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer |
Breast surgery, Magnetic resonance imaging, Mammography |
Active, not recruiting |
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy |
Educational Intervention, Text Message-based Navigation Intervention, Motivational Interviewing, Best Practice, Questionnaire Administration, Quality-of-Life Assessment |
Recruiting |
Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer |
Best Practice, Informational Intervention, Informational Intervention with Coaching, Questionnaire Administration |
Active, not recruiting |
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer |
Naloxegol, Placebo, Laboratory Biomarker Analysis, Quality-of-Life Assessment |
Active, not recruiting |
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial |
Laser Therapy, Quality of Life Assessment, Questionnaire Administration, Sham Intervention |
Not yet recruiting |
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) |
Monosialotetrahexosylganglioside, Paclitaxel, Placebo Administration, Quality-of-life assessment, Questionnaire Administration |
Recruiting |